Skip to content
Strength & muscleResearch article3 min read

Body fat percentage, not BMI, shows obesity as a risk for sarcopenia in 1637 older adults

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:The role of obesity in sarcopenia and the optimal body composition to prevent against sarcopenia and obesity. · Frontiers in endocrinology · 2023 · Original paper ↗

Key takeaway

In 1637 adults aged 60 or older, obesity defined by body fat percentage (BF%) was linked to higher odds of sarcopenia (OR 1.38, 95% CI 1.13-1.69), while obesity defined by BMI was linked to lower odds (OR 0.69, 95% CI 0.56-0.86). This is a single cross-sectional snapshot using bioelectrical impedance, so it cannot show which body composition causes sarcopenia.

Study design

Research article

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Older people with low muscle and high fat, called sarcopenic obesity, tend to have poor outcomes, yet how obesity relates to sarcopenia depends on how obesity is defined. The authors examined the relationship between obesity and sarcopenia and looked for the body fat and muscle balance best for older people.

Who and how

Cross-sectional study of 1637 participants aged 60 years or above (mean 74.8 years, SD 7.8). Muscle and fat indicators came from bioelectrical impedance analysis, and handgrip strength was measured. Sarcopenia was diagnosed from predicted appendicular skeletal muscle mass and function. Obesity was defined by body mass index (BMI) or by BF%. Correlations used Pearson's coefficient, and odds ratios (OR) for sarcopenia by obesity status were estimated with the Pearson Chi-Square test. The abstract does not report the setting or adjustments.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Defined by BMI, obesity was associated with lower odds of sarcopenia (OR 0.69, 95% CI 0.56-0.86; p = 0.001). Defined by BF%, it was associated with higher odds (OR 1.38, 95% CI 1.13-1.69; p = 0.002).
  2. 2
    Muscle indicators and fat mass were both positively correlated with BMI and body weight (p < 0.05), but muscle mass and strength were negatively related to appendicular fat mass percentage (p < 0.05).
  3. 3
    Sarcopenia risk fell as BMI rose in both sexes. It rose with higher BF% in men but followed a U-shaped curve in women.
  4. 4
    The authors suggest BF% of 26.0-34.6% for older women and below 23.9% for older men for preventing sarcopenia and obesity.

Limits & uncertainty

  1. 1
    It is cross-sectional, so it cannot show whether body fat leads to sarcopenia or the reverse.
  2. 2
    Muscle and fat came from bioelectrical impedance and predicted muscle mass, which are estimates rather than imaging scans.
  3. 3
    The odds ratios come from a chi-square approach, and the abstract does not report adjustment for age or other factors; the recommended BF% ranges are the authors' proposals, not tested targets.
  4. 4
    This reading is based on the abstract only.

What to take from it

BMI alone can mislead in older age: a higher BMI looked protective here, while a high body fat percentage looked harmful. Keeping muscle and strength matters as much as weight. Treat the suggested BF% ranges as research estimates, not personal targets, and discuss body composition and strength training with your clinician.

Reading your own data

Smart scales and bioimpedance devices report body fat percentage, and handgrip is a simple strength check. These estimates differ between devices and shift with hydration, so use the same device at the same time of day and follow multi-week trends rather than single readings.

How to read this evidence

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Elderly people with low lean and high fat mass, are diagnosed with sarcopenic obesity (SO), and often have poor clinical outcomes. This study aimed to explore the relationship between obesity and sarcopenia, and the optimal proportion of fat and muscle for old individuals.

Methods

Participants aged 60 years or above were instructed to perform bioelectrical impedance analysis to obtain the muscle and fat indicators, and handgrip strength was also performed. Sarcopenia was diagnosed according to predicted appendicular skeletal muscle mass and function. Body mass index (BMI) and body fat percentage (BF%) were used to define obesity. The association of muscle and fat indicators were analyzed by Pearson's correlation coefficient. Pearson Chi-Square test was utilized to estimate odds ratios (OR) and 95% confidence intervals (CI) on the risk of sarcopenia according to obesity status.

Results

1637 old subjects (74.8 ± 7.8 years) participated in this study. Not only fat mass, but also muscle indicators were positively correlated to BMI and body weight (p < 0.05). Absolute muscle and fat mass in different positions had positive associations (p < 0.05). Muscle mass and strength were negatively related to appendicular fat mass percentage (p < 0.05). When defined by BMI (OR = 0.69, 95% CI [0.56, 0.86]; p = 0.001), obesity was a protective factor for sarcopenia, whilst it was a risk factor when using BF% (OR = 1.38, 95% CI [1.13, 1.69]; p = 0.002) as the definition. The risk of sarcopenia reduced with the increase of BMI in both genders. It was increased with raised BF% in males but displayed a U-shaped curve for females. BF% 26.0-34.6% in old females and lower than 23.9% in old males are recommended for sarcopenia and obesity prevention.

Conclusion

Skeletal muscle mass had strong positive relationship with absolute fat mass but negative associations with the percentage of appendicular fat mass. Obesity was a risk factor of sarcopenia when defined by BF% instead of BMI. The management of BF% can accurately help elderly people prevent against both sarcopenia and obesity.

Sources & attribution

The role of obesity in sarcopenia and the optimal body composition to prevent against sarcopenia and obesity.

Liu C, Cheng KY, Tong X, Cheung WH, Chow SK, Law SW, Wong RMY.

Frontiers in endocrinology · 2023-03-01

DOI: 10.3389/fendo.2023.1077255 ↗PubMed · 36936175 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Overview of reviews

ACSM review of 137 reviews: resistance training works, and few programme details matter

The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.

Medicine & Science in Sports & Exercise

In-depth explainersRead study →
·Trial meta-analysis

Nearly every resistance training plan beat no exercise; heavy loads led for strength

In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.

British Journal of Sports Medicine

In-depth explainersRead study →
·Observational meta-analysis

Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes

Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.

British Journal of Sports Medicine

In-depth explainersRead study →
·Trial meta-analysis

Protein supplements and weight training: small extra gains, smaller in older adults

Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.

British Journal of Sports Medicine

In-depth explainersRead study →
Strength & muscle →